Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?

Antimicrob Agents Chemother. 2000 Jan;44(1):39-42. doi: 10.1128/AAC.44.1.39-42.2000.

Abstract

Aminoglycoside acetyltransferase was detected in Mycobacterium kansasii and M. fortuitum but not in M. avium-M. intracellulare when they were screened by a radioassay. Aminoglycoside phosphotransferase and nucleotidyltransferase activities were absent from all three species tested. Acetyltransferases from both M. kansasii and M. fortuitum displayed relatively high K(m)s, all at the millimolar level, for substrates including tobramycin, neomycin, and kanamycin A. The K(m) of each substrate was well above the corresponding maximum achievable level in serum. The low affinities of these enzymes for their substrates suggested that drug modification in vivo was very unlikely. Among the various substrates tested, no apparent positive correlation was found between substrate affinity and resistance level. The presence of aminoglycoside-modifying enzymes in these mycobacterial species was therefore not shown to confer resistance to aminoglycosides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyltransferases / metabolism*
  • Aminoglycosides
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial
  • Kanamycin Kinase / metabolism*
  • Mycobacterium avium Complex / drug effects*
  • Mycobacterium fortuitum / drug effects*
  • Mycobacterium kansasii / drug effects*
  • Nucleotidyltransferases / metabolism*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Acetyltransferases
  • aminoglycoside acetyltransferase
  • Kanamycin Kinase
  • Nucleotidyltransferases
  • gentamicin 2''-nucleotidyltransferase